John S. Montalbano insider trades
Open-market stock purchases and sales by John S. Montalbano, Director at AbCellera Biologics Inc, from SEC Form 4 filings since Nov 18, 2020.
Track record: 70% of 10 scored buys are up 5% or more since purchase, averaging +72%.
Companies traded
- ABCL AbCellera Biologics Inc: 12 buys, last Aug 18, 2026